Study of Rituximab, Gemcitabine, Dexamethasone, and Platinum with or without Selinexor for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Tebentafusp and Drug Combination for Patients with Advanced Uveal Melanoma
Not recruiting
Investigated Drugs:
Study of Pembrolizumab, Pemetrexed, and Carboplatin for Patients with Advanced Stage Non-Small Cell Lung Cancer (NSCLC)
Not recruiting
Investigated Diseases:Investigated Drugs:
powered by
